The Impact of Capital Structure Choice on the Innovation of High-Risk Industry in United States Under Exchange Rate Volatility: Lessons Learned from United States’ Pharmaceutical Companies (2018–2024)

Additional Metadata
Keywords	Financial leverage, R&D intensity, exchange rate volatility (ERV), innovation, capital structure, pharmaceutical
Thesis Advisor	Gejadze, Maia, Mulder, Arjen
Persistent URL	hdl.handle.net/2105/79672
Series	Finance & Investments
Organisation	Rotterdam School of Management
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Shafa Aulia Putra Wibowo, Shaul. (2025). The Impact of Capital Structure Choice on the Innovation of High-Risk Industry in United States Under Exchange Rate Volatility: Lessons Learned from United States’ Pharmaceutical Companies (2018–2024). In Finance & Investments.http://hdl.handle.net/2105/79672

Publication